FSCN-1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition

Resistance to chemotherapy drugs remains a significant problem for the treatment of many types of cancer. Fascin-1 (FSCN-1) is an actin-bundling protein involved in the invasion and metastasis of a variety of tumors. However, its involvement in drug resistance in hepatocellular carcinoma (HCC) remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuanbiao, Lu, Yi, Zhang, Chengwu, Huang, Dongsheng, Wu, Weiding, Zhang, Yuhua, Shen, Jian, Cai, Ying, Chen, Wei, Yao, Weifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873898/
https://www.ncbi.nlm.nih.gov/pubmed/29568938
http://dx.doi.org/10.3892/ijo.2018.4327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873898/
https://www.ncbi.nlm.nih.gov/pubmed/29568938
http://dx.doi.org/10.3892/ijo.2018.4327

Ejemplares similares